rs73302197

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_003482.4(KMT2D):​c.6807C>T​(p.Ser2269Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,610,722 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.013 ( 48 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 46 hom. )

Consequence

KMT2D
NM_003482.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -4.16
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 12-49040963-G-A is Benign according to our data. Variant chr12-49040963-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 158780.We mark this variant Likely_benign, oryginal submissions are: {Benign=5, Uncertain_significance=1}.
BP7
Synonymous conserved (PhyloP=-4.16 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0128 (1952/152190) while in subpopulation AFR AF= 0.0441 (1829/41512). AF 95% confidence interval is 0.0424. There are 48 homozygotes in gnomad4. There are 917 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1952 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.6807C>T p.Ser2269Ser synonymous_variant Exon 32 of 55 ENST00000301067.12 NP_003473.3 O14686-1Q59FG6Q6PIA1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.6807C>T p.Ser2269Ser synonymous_variant Exon 32 of 55 5 NM_003482.4 ENSP00000301067.7 O14686-1

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1948
AN:
152072
Hom.:
48
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0441
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00557
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.00332
AC:
815
AN:
245710
Hom.:
19
AF XY:
0.00229
AC XY:
306
AN XY:
133414
show subpopulations
Gnomad AFR exome
AF:
0.0445
Gnomad AMR exome
AF:
0.00251
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000660
Gnomad FIN exome
AF:
0.000607
Gnomad NFE exome
AF:
0.000153
Gnomad OTH exome
AF:
0.00203
GnomAD4 exome
AF:
0.00133
AC:
1938
AN:
1458532
Hom.:
46
Cov.:
35
AF XY:
0.00117
AC XY:
846
AN XY:
725366
show subpopulations
Gnomad4 AFR exome
AF:
0.0450
Gnomad4 AMR exome
AF:
0.00289
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000581
Gnomad4 FIN exome
AF:
0.000506
Gnomad4 NFE exome
AF:
0.000107
Gnomad4 OTH exome
AF:
0.00256
GnomAD4 genome
AF:
0.0128
AC:
1952
AN:
152190
Hom.:
48
Cov.:
32
AF XY:
0.0123
AC XY:
917
AN XY:
74414
show subpopulations
Gnomad4 AFR
AF:
0.0441
Gnomad4 AMR
AF:
0.00556
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000376
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.00610
Hom.:
10
Bravo
AF:
0.0143
Asia WGS
AF:
0.00318
AC:
12
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000297

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Kabuki syndrome 1 Uncertain:1Benign:1
Sep 20, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 04, 2013
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Feb 16, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 02, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Kabuki syndrome Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Nov 07, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
0.017
DANN
Benign
0.73
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73302197; hg19: chr12-49434746; COSMIC: COSV56422193; COSMIC: COSV56422193; API